Investigating Groundbreaking Treatments for Rare Disease

Gene therapy has the potential to transform how we manage rare genetic diseases like hemophilia, Duchenne Muscular Dystrophy and others by addressing their root cause – genetic mutations.

The Power of Science behind gene therapy inspires our colleagues, like Bob Smith, SVP, Global Gene Therapy Business, to investigate this groundbreaking technology that could, if successful, bring disease-modification to millions of patients worldwide.

Visit our Annual Review to learn more at www.pfizer.com/annual.